If you’re suffering from stabbing pain, numbness, tingling or a burning sensation in your arms, legs, hands or feet, you may ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

Researchers found that the pooled prevalence of those reporting chronic painful neuropathy among those diagnosed with chemotherapy-induced peripheral neuropathy was estimated at 41.22%.

The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

The causal relationship of liver disease to neuropathy has been questioned. This study was designed to evaluate the incidence and character of peripheral neuropathy in patients with liver cirrhosis.

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

aDepartment of Medicine, Hospital de Apoyo Chepén, Chepén, Peru bDepartment of Family Medicine, Hospital de Apoyo Chepén, Chepén, Peru cDepartment of Internal Medicine, Hospital de Apoyo Chepén, ...

Scott, who was using natural supplements to help manage her chronic health conditions, the first inkling that something was ...

Diabetes isn’t just about high blood sugar; it can cause strange symptoms like dark skin patches (acanthosis nigricans), ...

Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced ...